Guardant Health Inc. (GH)
NASDAQ
Closed
Oct 9, 2026
Day's Range
166.0352 wk Range
61.00Profile - GH - Guardant Health Inc.
Profile
Mic Code
XNGS
Sector
Healthcare
Industry
Diagnostics & Research
Employees
2.49K
Guardant Health Inc. is a precision oncology company that develops blood- and tissue-based tests, data sets, and analytics to support cancer detection and treatment decisions. Its product portfolio includes liquid biopsy tests for tumor mutation profiling, molecular residual disease monitoring, tissue-based genomic profiling, and colorectal cancer screening. The company’s solutions are used across clinical care and research settings to help identify biomarkers, track recurrence, and provide molecular insights from tumor-derived material. Guardant Health serves healthcare providers, laboratories, researchers, and life sciences partners in the United States and internationally, with a focus on noninvasive diagnostics and cancer monitoring. Headquartered in Palo Alto, California, Guardant Health plays a significant role in the growing market for precision medicine and advanced oncology diagnostics.
Profile Details
Type
Common Stock
Address
3100 Hanover Street
City
Palo Alto
State
CA
Zip
94304
Country
United States
Phone
855 698 8887
Key Executives - GH - Guardant Health Inc.
Key executives
Cross Listings - GH - Guardant Health Inc.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
